SHEHNAAZ SULIMAN Insider Trading $TBPH Theravance Biopharma, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for SHEHNAAZ SULIMAN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of SHEHNAAZ SULIMAN. SHEHNAAZ SULIMAN is Director in Ultragenyx Pharmaceutical Inc. ($RARE) and SVP, Corp Dev & Strategy in Theravance Biopharma, Inc. ($TBPH) and President and COO in Alector, Inc. ($ALEC) and Director in 10x Genomics, Inc. ($TXG).
SHEHNAAZ SULIMAN in Theravance Biopharma, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of SHEHNAAZ SULIMAN: SVP, Corp Dev & Strategy
Holdings: 97,198 shares
Current Value: $2,974,259
Latest Transaction: Feb 22 2019
$TBPH Market Capitalization: $1.64B
$TBPH Previous Close: $30.60
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of SHEHNAAZ SULIMAN in Theravance Biopharma, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, TXG, ALEC, TBPH, RARE
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 22 2019 | TBPH | Theravance Biophar ... | SULIMAN SHEHNAAZ | SVP, Corp Dev & Str ... | Payment of Exercise | F | 27.00 | 5,763 | 155,601 | 97,198 | 103 K to 97.2 K (-5.60 %) |
| Feb 22 2018 | TBPH | Theravance Biophar ... | SULIMAN SHEHNAAZ | SVP, Corp Dev & Str ... | Payment of Exercise | F | 29.09 | 8,770 | 255,119 | 101,230 | 110 K to 101.2 K (-7.97 %) |
| Feb 14 2018 | TBPH | Theravance Biophar ... | SULIMAN SHEHNAAZ | SVP, Corp Dev & Str ... | Grant | A | 0.00 | 25,000 | 0 | 110,000 | 85 K to 110 K (+29.41 %) |
| Feb 14 2018 | TBPH | Theravance Biophar ... | SULIMAN SHEHNAAZ | SVP, Corp Dev & Str ... | Grant | A | 0.00 | 65,000 | 0 | 85,000 | 20 K to 85 K (+325.00 %) |
| Aug 03 2017 | TBPH | Theravance Biophar ... | SULIMAN SHEHNAAZ | SVP, Corp Dev & Str ... | Option Exercise | A | 31.93 | 170,000 | 5,428,100 | 170,000 | |
| Aug 03 2017 | TBPH | Theravance Biophar ... | SULIMAN SHEHNAAZ | SVP, Corp Dev & Str ... | Grant | A | 0.00 | 20,000 | 0 | 20,000 | 0 to 20 K |
Page: 1